BOSTON, July 9, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2022 financial results at 6:00 am EDT on Wednesday, August 11, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on August 11, 2021.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 1674067
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/i5w7z4hk
A replay of the conference call and webcast will be available for one year beginning on August 11, 2021 at 11:00 a.m. EDT using the conference call webcast link provided in this press release.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Olga Guyette, Director-Investor Relations
SOURCE Haemonetics Corporation